ICPerMed stands for International Consortium for Personalised Medicine: 
Its members are both public and private “not-for-profit” organisations, whose common aim is fostering PM development and research in the EU. The main decisional organ is the Executive Committee, supported by Challenge Groups and Action Item Groups in their action to implementing ICPerMed’s Action Plan.

About us

Our projects within the ICPerMed Family

IC2Permed logo Sino-EU PerMed Logo

The purpose of the IC2Permed project is to foster improved development of PM policies, innovation and research, by bringing the EU and China’s perspective on the field closer and more integrated.

The key word of the next steps of the IC2PerMed project is 'expertise': many experts in PM will be asked to share knowledge and opinions, in order to guarantee the best achievable approaches to the different topics. Their interaction will be promoted in the form of three multidisciplinary Working Groups (WG), handling the topics of 'Shaping sustainable healthcare' (WG1), 'Innovation and market' (WG2) and 'Research and clinical studies' (WG3).


IC2PerMed: This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 874694.

The Sino-EU PerMed project focuses on science and technology cooperation between China and the EU in the field of Personalised Medicine (PM).

The project aims to identify PM-related research and health system stakeholders in Europe and China. It will also pinpoint and address existing gaps, and analyse the potential and benefits of existing and new PM collaborations between Europe and China. In addition, Sino-EU PerMed aims to establish links between relevant organisations and research centres that have an interest in PM research and innovation policy. Suitable and interested Chinese organisations will be supported to participate in ICPerMed as well as in its working groups, workshops, conferences and other events and initiatives.


Sino-EU Permed: This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme und Grant Agreement No 874556.


This newsletter is provided by:

European and International Cooperation
Heinrich-Konen-Str. 1
53227 Bonn | Germany
E-mail: sino-eu-permed@dlr.de

For information about data protection, please see our Privacy Policy.

To unsubscribe, please click here.